OpenLegislation

Annex

United Kingdom

Original text. Later amendments are not shown.

In point A of Annex III to Directive 2004/37/EC, the following rows are added:

Inhalable fraction.

Inhalable fraction. Respirable fraction in those Member States that implement, on the date of the entry into force of this Directive, a biomonitoring system with a biological limit value not exceeding 0,002 mg Cd/g creatinine in urine.

The substance can cause sensitisation of the skin and of the respiratory tract.

The substance can cause sensitisation of the skin.’.

Name of agentEC No (1)CAS No (2)Limit valuesNotationTransitional measures
8 hours (3)Short-term (4)
mg/m3 (5)ppm (6)f/ml (7)mg/m3 (5)ppm (6)f/ml (7)
‘Cadmium and its inorganic compounds——0,001f1 —————Limit value 0,004 mg/m3 f2 until 11 July 2027
Beryllium and inorganic beryllium compounds——0,0002 —————dermal and respiratory sensitisationf3 Limit value 0,0006 mg/m3 until 11 July 2026
Arsenic acid and its salts, as well as inorganic arsenic compounds——0,01 ——————For the copper smelting sector, the limit value shall apply from 11 July 2023
Formaldehyde200-001-850-00-00,370,3—0,740,6—dermal sensitisationf4 Limit value of 0,62 mg/m3 or 0,5 ppm (3) for the health care, funeral and embalming sectors until 11 July 2024
4,4′-Methylene-bis (2-chloroaniline)202-918-9101-14-40,01—————skin (10)

Annotations

Footnotes

f1

Inhalable fraction.

f2

Inhalable fraction. Respirable fraction in those Member States that implement, on the date of the entry into force of this Directive, a biomonitoring system with a biological limit value not exceeding 0,002 mg Cd/g creatinine in urine.

f3

The substance can cause sensitisation of the skin and of the respiratory tract.

f4

The substance can cause sensitisation of the skin.’.